These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 10949931)

  • 21. Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways.
    Qin C; Samudio I; Ngwenya S; Safe S
    Mol Carcinog; 2004 Jul; 40(3):160-70. PubMed ID: 15224348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
    Laenen K; Haegeman G; Vanhoenacker P
    Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site.
    Wang CH; Tsao YP; Chen HJ; Chen HL; Wang HW; Chen SL
    Biochem Biophys Res Commun; 2000 Apr; 270(1):303-10. PubMed ID: 10733944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.
    Xie W; Su K; Wang D; Paterson AJ; Kudlow JE
    Anticancer Res; 1997; 17(4A):2627-33. PubMed ID: 9252692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.
    Billon N; Carlisi D; Datto MB; van Grunsven LA; Watt A; Wang XF; Rudkin BB
    Oncogene; 1999 May; 18(18):2872-82. PubMed ID: 10362258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.
    Kim YK; Han JW; Woo YN; Chun JK; Yoo JY; Cho EJ; Hong S; Lee HY; Lee YW; Lee HW
    Oncogene; 2003 Sep; 22(38):6023-31. PubMed ID: 12955081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin induction of apolipoprotein AI, role of Sp1.
    Lam JK; Matsubara S; Mihara K; Zheng XL; Mooradian AD; Wong NC
    Biochemistry; 2003 Mar; 42(9):2680-90. PubMed ID: 12614163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor Sp1 mediates p38MAPK-dependent activation of the p21WAF1 gene promoter in vascular smooth muscle cells by pyrrolidine dithiocarbamate.
    Moon SK; Jung SY; Kim CH
    Biochem Biophys Res Commun; 2004 Apr; 316(3):605-11. PubMed ID: 15033443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
    Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
    Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.
    Hong W; Chen L; Li J; Yao Z
    Biochem Biophys Res Commun; 2010 May; 396(2):299-303. PubMed ID: 20406620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for cell-specific regulation of the NADPH-cytochrome P450 oxidoreductase gene.
    O'Leary KA; Kasper CB
    Arch Biochem Biophys; 2000 Jul; 379(1):97-108. PubMed ID: 10864447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis.
    Shao ZM; Alpaugh ML; Fontana JA; Barsky SH
    J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta.
    Watanabe T; Inoue S; Ogawa S; Ishii Y; Hiroi H; Ikeda K; Orimo A; Muramatsu M
    Biochem Biophys Res Commun; 1997 Jul; 236(1):140-5. PubMed ID: 9223441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.